Zavante Therapeutics' Series A Round

Zavante Therapeutics raised a round of funding on March 30, 2016.

Zavante Therapeutics, formerly SG Pharmaceuticals, is a clinical-stage biopharmaceutical company focused on developing therapies to improve the outcomes of hospitalized patients. The Company develops …

Articles about Zavante Therapeutics' Series A Round: